Skip to content
BYO LUX
BYO LUXBe Your Own Luxury
치료 목록
Cosmetic

Relfydess (Ready-to-Use Liquid Toxin)

World's first ready-to-use liquid botulinum toxin lasting 6 months

시술 시간
10-20분
다운타임
0일
권장 횟수
6개월매 (연 2회)

이 치료에 대해

Relfydess (RelabotulinumtoxinA) by Galderma is the world's first ready-to-use liquid botulinum toxin A. PEARL Technology™ (Precipitation, Extraction, Activity-preserving Refined Liquid) stabilizes the toxin in liquid form without reconstitution.

Phase 3 READY-1/READY-2 trials achieved >98% responder rate for glabellar lines, with 24-27 week duration (~1.5x longer than traditional Botox). Approved in 20+ countries; FDA BLA accepted in 2026.

작용 기전

PEARL Technology™ maintains botulinum toxin A molecular structure and bioactivity in liquid state. Cleaves SNAP-25 at neuromuscular junction for sustained 6-month acetylcholine suppression. Extended duration attributed to molecular stability in liquid form and uniform diffusion pattern.

적응증

주름·잔주름처짐·윤곽

기대 효과

Rapid onset at 48-72 hours. >98% responder rate for glabellar lines. Duration 24-27 weeks (~6 months), requiring only 2 treatments per year. Very high patient satisfaction.

임상 근거

Galderma Phase 3 Data (2026)
READY-1 and READY-2: Phase 3 Trials of RelabotulinumtoxinA for Glabellar Lines. Presented at TOXINS 2026
해당 연구에서 임상적 개선이 보고되었습니다(자세한 내용은 원문 논문 참조).
Carruthers A, Solish N, et al. (2025)
Efficacy and Safety of Ready-to-Use Liquid Botulinum Toxin. Dermatol Surg
해당 연구에서 임상적 개선이 보고되었습니다(자세한 내용은 원문 논문 참조).
Galderma Regulatory Filing (2026)
Relfydess BLA Submission to FDA. FDA
해당 연구에서 임상적 개선이 보고되었습니다(자세한 내용은 원문 논문 참조).

위험 및 부작용

Headache (most common), transient injection site reactions. Ptosis risk comparable to conventional toxins. Requires refrigeration (2-8°C). Not yet approved in Japan.

이 치료에 관심이 있으신가요?

AI 피부 진단으로 현재 피부 상태를 확인해 보세요

AI 피부 진단 받기예약하기

다른 치료 보기

LaserPicoSure Pro자세히 보기 LaserFractional Laser자세히 보기 LaserPhotofacial IPL (Stellar M22)자세히 보기 Anti-AgingThermage FLX자세히 보기